Dr. Arundathi Jayatilleke, MD

Dr. Jayatilleke practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Jayatilleke's NPI, 1427232834, was assigned on December 20, 2007. Dr. Jayatilleke holds Pennsylvania license MD441951.

Dr. Jayatilleke's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Jayatilleke's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Jayatilleke is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Jayatilleke to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jayatilleke practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Jayatilleke's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Jayatilleke is licensed in Pennsylvania.

CMS data shows 320 Medicare services from Dr. Jayatilleke across 4 procedure codes in 2024, for 127 Medicare patients. Medicare paid $14,423 for them.

CMS counts 127 Medicare patients who saw Dr. Jayatilleke in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have arthritis, and 75% have high blood pressure. 43% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jayatilleke's median patient age at 61, with 77% women.

In 2024, Dr. Jayatilleke wrote 3,153 Medicare Part D claims for 270 patients. 82% of them were for generic drugs. CMS names the drug for 2,936 of them, across 48 drugs with 11 or more claims each, at $2,402,427 in total drug cost. In 2023, CMS named 3,075 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Jayatilleke for performance year 2024, reported as part of a group. Dr. Jayatilleke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jayatilleke as offering telehealth.

Dmand AI links 15 papers to Dr. Jayatilleke, published from 2014 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Rheumatology, COVID-19 and Decision Making, Shared. Dr. Jayatilleke has published most often in Semin Arthritis Rheum. Dr. Jayatilleke's most frequent co-authors are Jean W. Liew, MD, Zachary S. Wallace, MD and Adam Kilian, MD.

CMS Open Payments shows 12 general payments to Dr. Jayatilleke from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 96% of the total. GlaxoSmithKline, LLC. paid the most, $131.